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ABSTRACT
Human umbilical cord blood (CB) has attracted much attention as a
reservoir for functional hematopoietic stem and progenitor cells, and,
recently, as a source of blood-borne fibroblasts (CB-BFs). Previously,
we demonstrated that bone marrow stromal cell (BMSC) and CB-BF
pellet cultures make cartilage in vitro. Furthermore, upon in vivo
transplantation, BMSC pellets remodelled into miniature bone/marrow
organoids. Using this in vivo model, we asked whether CB-BF
populations that express characteristics of the hematopoietic stem cell
(HSC) niche contain precursors that reform the niche. CB ossicles were
regularly observed upon transplantation. Compared with BM ossicles,
CB ossicles showed a predominance of red marrow over yellow
marrow, as demonstrated by histomorphological analyses and the
number of hematopoietic cells isolated within ossicles. Marrow cavities
from CB and BM ossicles included donor-derived CD146-expressing
osteoprogenitors and host-derived mature hematopoietic cells,
clonogenic lineage-committed progenitors and HSCs. Furthermore,
human CD34+ cells transplanted into ossicle-bearing mice engrafted
and maintained human HSCs in the niche. Our data indicate that CB-
BFs are able to recapitulate the conditions by which the bone marrow
microenvironment is formed andestablish completeHSCniches, which
are functionally supportive of hematopoietic tissue.
KEY WORDS: Umbilical cord blood, Cord blood-borne fibroblasts,
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INTRODUCTION
The current view is that multipotent skeletal stem cells, a subset of
bone marrow stromal cells (BMSCs) within the bone marrow (BM)
compartment, are the prime candidate for establishing, transferring
and maintaining the hematopoietic stem cell (HSC) niche, a unique
niche made of two stem cells (Sacchetti et al., 2007; Méndez-
Ferrer et al., 2010; Bianco, 2011). Whether other stromal cells or
blood-borne fibroblasts derived from different adult or fetal
sources share this property with BMSCs and are similarly able
to recreate a completely humanized hematopoietic niche is not
known. Using an experimental model in which cells are
resuspended in a Matrigel equivalent, Reinisch et al. compared
the capacity of cells derived from different sources (bone marrow
stroma, white adipose tissue, umbilical cord, skin) to give rise to a
functional hematopoietic niche and concluded that BMSCs,
exclusively, have the ability to form a heterotopic bone/marrow
organoid (Reinisch et al., 2015).
Umbilical cord blood (CB) is an intriguing source of
hematopoietic and non-hematopoietic progenitors. Within the
non-hematopoietic fraction, a rare population of cells that can
become adherent, defined as cord blood-borne fibroblasts (CB-
BFs), can be isolated. The question regarding their origin is still
unanswered, as it is not completely understood whether these cells
normally circulate in cord blood or whether they are skeletal
progenitors located at sites of active skeletal growth that accidentally
spill over into the bloodstream.
CB-BFs exhibit a morphological, phenotypical and molecular
profile that is distinct from other cells of fetal and adult origin
(Secco et al., 2009; Bosch et al., 2013; Pievani et al., 2014; Kern
et al., 2006; Bieback et al., 2008; Rebelatto et al., 2008). In vitro,
CB-BFs display osteogenic and chondrogenic differentiation
potential (Pievani et al., 2014), whereas they have a reduced or
virtually absent capacity to generate adipocyte-like cells (Kern et al.,
2006; Goodwin et al., 2001; Zhang et al., 2011; Bieback et al., 2008;
Karagianni et al., 2013). When transplanted in vivo with
osteoconductive ceramic scaffolds, CB-BFs are able to form
histology-proven bone (Zhang et al., 2011; Liedtke et al., 2016;
Sacchetti et al., 2016). Interestingly, we have also demonstrated that
CB-BFs consistently form cartilage in open heterotopic transplants,
a property that is usually not observed in BMSCs. However, unlike
BMSCs, which have the specific capacity of generating bone and a
bone marrow stroma that supports functional hematopoiesis, CB-
BFs do not establish a hematopoietic microenvironment in ceramic
scaffold-based transplants (Sacchetti et al., 2016).
Recently, we have developed an in vivo experimental model
in which the ability of human BMSCs to generate a bone/bone
marrow organ was optimized in the complete absence of any
exogenous synthetic scaffold/carrier/biomaterial. In this system,
cartilage pellets, produced ex vivo and subsequently transplanted
in vivo, remodelled into miniature ossicles with perfect architecture
(Serafini et al., 2014). These pellet-derived ossicles include
donor-derived bone and marrow stroma, as a result of
phenotypical reversion of differentiated chondrocytes, that
become subsequently filled by a functional hematopoietic tissue
provided by the host.
In this study, we transplanted chondroid rudiments generated
in vitro from CB-BFs to explore the ability of this cell populationReceived 29 July 2016; Accepted 10 January 2017
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to establish a vascularized, extramedullary hematopoietic
microenvironment in vivo. Moreover, we aimed to compare
ossicles (i.e. rudiments including bone and BM) obtained from
CB-BFs and BMSCs (hereafter termed CB ossicles and BM
ossicles, respectively) with respect to their architectural and cellular
features, and their ability to support both murine and human HSC
homing and maintenance. Finally, we integrated our in vivo findings
with in vitro data aimed at evaluating the expression of HSC
maintenance genes and the capacity of CB-BFs to support human
HSCs.
RESULTS
CB-BFs are skeletogenic and form pellet-derived ossicles
with peculiar histological features
We evaluated the skeletogenic potential of BMSCs and CB-BFs by
performing quantitative gene expression of known osteogenic and
chondrogenic genes at baseline in monolayer cultures without
addition of any inducing factors. We found a similar expression of
RUNX2, SPP1, BGLAP, ALPL, ACAN, RUNX3 and DLX6 in both
BMSCs and CB-BFs (Fig. 1A). We further verified the skeletogenic
property of CB-BFs in vivo, evaluating their capacity to generate
pellet-derived heterotopic ossicles, in comparison with control
BMSCs. For this purpose, we established pellet cultures from
CB-BFs and BMSCs, and incubated them with TGFβ1 for 3 weeks
prior to in vivo transplantation into the subcutaneous tissue of
immunodeficient mice. Untransplanted cartilage pellets obtained at
the end of the culture period from both CB-BFs and BMSCs showed
a similar histological appearance (Fig. 1C). Both types of organoids
consisted of unmineralized cartilagenous tissue (negative von Kossa
staining, data not shown) in which similar levels of transcripts for
proteoglycans and chondrocyte-associated markers, such as
COL2A1, COL10A1, SOX9 and ACAN were detected (Fig. 1B).
However, the mean area of the untransplanted cartilage pellets
obtained from CB-BFs was significantly greater than that of the
pellets generated from BMSCs (2.42±0.81 mm2 versus 0.84±
0.46 mm2; P=0.0066) (Fig. 1C, right).
Histological analysis of the transplants harvested after 8 weeks
in vivo demonstrated that complete heterotopic ossicles (i.e.
structures including bone and BM) had similarly developed in
samples generated by CB-BFs and by BMSCs (n=44 and 99,
respectively). The ossicles obtained from CB-BFs mimicked those
obtained from BMSCs (Fig. 1D). They demonstrated a striking
architectural resemblance to a normal bone/marrow organ and
consisted of an outer shell of cortical bone encasing spaces filled
with hematopoietic tissue, including erythroid, myeloid and
megakaryocytic lineages. However, quantitative histological
analysis revealed some differences between the two types of
ossicles. As with untransplanted cartilage pellets, the ossicles
generated by CB-BFs were significantly larger in size compared
with those generated by BMSCs [3.09±0.88 mm2 (mean±s.d.)
versus 0.85±0.26 mm2; P=0.04] (Fig. 1D, right). Interestingly, this
dimensional discrepancy occurred even though the proportion of
cells in S phase in cultures (at passages 3-4) and positivity for the
cell proliferation antigen, Ki-67, in cartilage pellets (after 1 week of
differentiation) were indistinguishable between CB-BFs and
BMSCs (cells in S phase: CB-BFs versus BMSCs, 16.19±2.27%
versus 19.00±2.93%; P=0.21; percentage of Ki-67 positive cells:
CB-pellet versus BM-pellet, 7.48±4.90% versus 6.74±4.73%;
P=0.79) (data not shown).
In addition, compared with the ossicles generated by BMSCs,
the fraction of BM occupied by adipocytes was significantly
lower in the ossicles generated by CB-BFs (CB-BFs versus
BMSCs, 1.44±0.68 versus 12.82±7.28; P=0.04) (Fig. 1E). No
significant difference was detected by comparing the size of the
cartilage pellets with the size of the corresponding ossicles
generated by either CB-BFs or BMSCs (data not shown). In other
words, the size of cartilage pellets did not change after in vivo
transplantation.
Fig. 1. Chondroid pellets obtained fromCB-BFs can generate heterotopic
ossicles upon in vivo transplantation. (A) Baseline expression of
osteogenic- and chondrogenic-specific genes in BMSCs and CB-BFs (n=3).
(B) Upregulation of cartilage-related genes detected by quantitative RT-PCR
after 21 days of chondrogenic induction in BMSC (n=3) versus CB-BF pellets
(n=6). (C,D) Representative histological images of untransplanted cartilage
pellets and ossicles obtained from BMSCs (left) and CB-BFs (right) are shown
(C, upper, Alcian Blue; C, lower, Toluidine Blue; D, Haematoxylin and Eosin).
Graphs show histomorphometric analysis of the areas of both the
untransplanted cartilage pellets (C, right) and of the ossicles (D, right) obtained
from BMSCs compared with CB-BFs (n=6 versus n=3 pellets, respectively;
n=5 versus n=3 ossicles, respectively). Scale bars in C,D: 1 mm. (E)
Representative histological images of the BM tissue in ossicles generated by
transplantation of a cartilage pellet from either BMSCs (left) or CB-BFs (middle)
are shown (Sirius red stain). Graph shows the fraction of BM occupied by
adipocytes in the ossicles generated by BMSCs and CB-BFs (n=5 versus n=3,
respectively). The black triangles in both the histological images indicate bone
tissue. The arrows in the histological image of CB ossicles indicate sinusoids,
which are hard to see in the histological image of BM ossicle due to their
compression by the greater amount of adipose tissue (asterisks). Scale bars:
100 μm. P values indicated have been calculated with an unpaired two-tailed t-
test (*P<0.05, **P<0.01).
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Development of a complete hematopoietic stem cell niche
from CB-BFs
Similar to BMSCs, CB-BFs-derived ossicles demonstrated a
striking architectural resemblance to natural bone/marrow organs;
i.e. they featured a bone cortex encasing a marrow cavity containing
hematopoietic tissue, including systems of marrow sinusoids
(Fig. 1E). Bone cells (osteocytes and osteoblasts) were human in
origin throughout, as demonstrated by their nuclear
immunoreactivity for human-specific Lamin A/C (Fig. 2, top
panels); hematopoietic and bone marrow sinusoidal cells
(endothelial and peri-vascular cells) did not stain, confirming their
murine origin. Furthermore, in CB ossicles, as previously
demonstrated for BM ossicles (Serafini et al., 2014), we detected
the presence of human CD146-positive stromal cells associated with
the vessel wall (Fig. 2, bottom panels). The components of the
hematopoietic tissue within the ossicles were analysed after
collagenase digestion of CB and BM ossicles. Consistent with the
results of the histological analysis, the number of hematopoietic
cells harvested per ossicle was significantly higher in CB than in
BM ossicles (5.14±0.99×105 versus 2.80±1.14×105, respectively;
P=0.0057) (Fig. 3A). The composition of the collected cells was
further analysed by flow cytometry for different hematopoietic
lineages, showing similar proportions of erythroid cells (Ter-119+),
myeloid cells (Mac-1+, Gr-1+ or Gr1−/low) and megakaryocytes
(CD41+) in CB and BM ossicles, also in comparison with
orthotopic BM of the same animals (P values not significant)
(Fig. 3B). Both CB and BM ossicles contained Lin−/Sca-1+/c-Kit+
(LSK) progenitors with a similar frequency (0.134±0.041% versus
0.091±0.021%; P=0.079), which is reduced in comparison with
normal murine BM (0.263±0.083%; P<0.05) (Fig. 3C). We also
calculated the absolute number of LSK progenitors collected per
ossicle, showing that it was significantly higher in CB than in BM
ossicles (680.25±216.42 versus 325.80±85.19; P=0.011) (Fig. 3D).
Furthermore, to identify and enumerate the hematopoietic
progenitor cells, methylcellulose cultures were used. As shown in
Fig. 3E, both CB and BM ossicles contained a distribution of
progenitor cells comparable with control BM, showing the presence
of CFU-GEMM, BFU-E, CFU-GM, CFU-G and CFU-M.
Although not statistically significant, there was a trend for an
increase in the proportion of progenitor cells derived from CB
ossicles compared with BM ossicles. More hematopoietic
progenitor cells were present in the ossicles when compared with
peripheral blood (PB) harvested from the ossicle-bearing mice, in
which we mainly detected BFU-E. Furthermore, a panel of specific
markers was used to investigate the presence of HSCs and
progenitors in the ossicles (Fig. 3F). Interestingly, in CB and BM
ossicles, the frequency of putative long-term HSCs (LSK/CD34−/
Flk2−), short-term HSCs (LSK/CD34+/Flk2−) and multipotent
progenitors (MMP, LSK/CD34+/Flk2+) displayed a comparable
distribution with that found in BM derived from femurs. Similarly,
no major differences were observed in megakaryocyte-erythroid
[MEP, Lin−/c-Kit+/Sca-1−(LK)/FcγR−/CD34−], common myeloid
(CMP, LK/FcγR−/CD34+) and granulocyte-macrophage (GMP,
LK/FcγR+/CD34+) progenitors.
Engraftment of human hematopoietic stem cells into CB
ossicles
To investigate whether the in vivo generated CB ossicles could also
support human hematopoiesis, we developed a transplantation
protocol, as illustrated in Fig. 4A. Briefly, 3 weeks after
transplantation of the pellets (when vascular invasion is initiated
and formation of a primitive stroma is emerging), mice were
sublethally irradiated and inoculated with human cord blood
CD34+-enriched cells (h-CD34+ cells). Six weeks later, ossicles
were harvested and analysed for human cell engraftment together
with various hematopoietic organs, including BM, spleen and PB
of the same animals. Similar percentages of human CD45+ cells
were detected by flow cytometry in hematopoietic cells collected
from CB and BM ossicles, and comparable with the engraftment
observed in BM (Fig. 4B). Human CD45+ cells were also
detectable, although at lower levels, in the spleen and PB of
engrafted mice (Fig. 4B).
In addition, we evaluated the ability of human hematopoietic
progenitor cells to differentiate into committed hematopoietic cells
Fig. 2. Features of the stromal compartment in CB-
BF-derived ossicles. Confocal fluorescence images
to demonstrate the contribution of human CB-BFs cells
to the generation of the different tissues within the
heterotopic ossicles. Top panels show the expression of
huLamin A/C in the nuclear membrane of osteocytes
(arrows). Scattered human nuclei are also
immunolabelled among the hematopoietic cells, which
are negative and, thus, of mouse origin. Bottom panels
show the expression of hCD146 in stromal cells
associated with the vessel wall within the hematopoietic
marrow. Scale bars: 150 μm (top); 100 μm and 50 μm
(bottom left and bottom right, respectively). Cell nuclei
were stained with Topro-3 iodide.
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of distinct lineages within the ossicles. B cells were robustly
engrafted in both types of ossicles and in mouse BM (Fig. 4C).
Small percentages of human myeloid cells (CD33+, CD14+,
CD64+) were also detectable at comparable levels in BM ossicles,
CB ossicles and mouse BM. Similarly, human HSCs (CD34+) were
engrafted in ossicles derived from both sources and in mouse BM.
CB-BFs express markers that hallmark the HSC niche and
maintain HSCs ex vivo
Because culture-expanded human CB-BFs are capable of establishing
the hematopoietic microenvironment when transplanted as cartilage
pellets into immunodeficient mice, we then assessed their capacity to
maintain HSCs ex vivo. First, we evaluated their expression of
CD146, a marker of clonogenic human skeletal progenitors able to
establish the hematopoieticmicroenvironment (Sacchetti et al., 2007).
Human CB-BFs at passages 3-4 showed a similar level and extent of
CD146 expression by FACS analysis when compared with BMSCs at
the same passage (Fig. 5A). In addition, the ability of single cells
(colony-forming unit-fibroblasts) to generate colonies (colony-
forming efficiency) was comparable in both populations at passages
3-4, demonstrating that they have a comparable clonogenic capacity
and, consequently, progenitor frequency (Fig. 5B). Furthermore, CB-
BFs expressed HSC niche regulatory genes, such as CXCL12,
VCAM1, ANGPT1, KITLG, SPP1 and JAG1, confirming that the
HSC niche commitment of CB-BFs is already primed and regulated at
the transcriptional level. All of these genes were expressed to a similar
extent in CB-BFs and BMSCs, with the exception of CXCL12 and
VCAM1 (Fig. 5C).
Finally, we assessed their ability to maintain HSCs and
progenitors ex vivo. To this end, we co-cultured 105 h-CD34+
cells on an adherent CB-BF and BMSC confluent cultures. After
7 days, the total number of non-adherent hematopoietic cells was
reduced, but was similar in BMCSs and CB-BFs co-cultures (4.4±
2.4×104 versus 4.8±2.1×104; P=0.87) (Fig. 5D). Regarding the
differentiation state of h-CD34+ after 7 days of co-culture, no
significant differences in the percentages of CD34+/CD38+ and
CD34+/CD38− cells were observed under the different conditions.
In particular, the more undifferentiated population (CD34+/CD38−)
was similarly maintained by both CB-BFs and BMSCs (14.83±
4.49% versus 11.03±3.11%; P=0.29) (Fig. 5E).
We then used an in vitro clonogenic colony-forming unit (CFU)
assay to test the ability of BMSCs and CB-BFs to preserve the
Fig. 3. Features of murine hematopoietic
engraftment in heterotopic ossicles. (A) Number of
hematopoietic cells harvested from BM ossicles or CB
ossicles (n=94 versus 41 ossicles, respectively, from six
and five independent experiments, respectively;
**P<0.01, unpaired two-tailed t-test). (B) Comparison of
murine multilineage hematopoiesis in heterotopic BM
ossicles and CB ossicles, and in mouse femur BM
(n=16 versus 31 ossicles from three independent
experiments). (C) Representative profile of LSK cells in
ossicles derived from BMSCs and CB-BFs, and mouse
femur BM (left). Graph shows frequency of LSK cells
from explanted BM ossicles and CB ossicles, and
mouse femur BM [n=90 BM ossicles versus 31 CB
ossicles from five and four independent experiments;
*P<0.05, **P<0.01, unpaired two-tailed t-test].
(D) Number of LSK cells per ossicle evaluated in
explanted cells from BM ossicles and CB ossicles
(*P<0.05, unpaired two-tailed t-test). (E) Frequency of
various colony types generated from hematopoietic
cells from BM ossicles, CB ossicles, mouse femur BM
and peripheral blood (PB) (n=3 independent
experiments). (F) Representative cytofluorometric
analysis of murine HSCs and progenitors in mouse
femur BM, BM ossicles or CB ossicles. LT-HSCs (long-
term HSCs; LSK/CD34−/Flk2−), ST-HSCs (short-term
HSCs;LSK/CD34+/Flk2−), MPPs (multipotent
progenitors; LSK/CD34+/Flk2+), CMPs (common
myeloid progenitors; LK/FcγR−/CD34+), GMPs
(granulocyte/monocyte progenitors; LK/FcγR+/CD34+)
and MEPs (megakaryocyte/erythroid progenitors;
LK/FcγR−/CD34−) were gated as indicated.
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hematopoietic progenitor cell function of recovered cells. Equal
numbers of h-CD34+ cells that had been previously cultured for
7 days with CB-BFs or BMSCs were plated in methylcellulose and
hematopoietic colonies were counted after 14 days. No statistical
differences in the number and phenotype of CFUs obtained from
h-CD34+ cells previously co-cultured with both BMSCs and
CB-BFs were observed (Fig. 5F).
A xenotransplantation assay in NSG mice was used to evaluate
the in vivo SCID-repopulating function of h-CD34+ cells previously
co-cultured with BMSCs or CB-BFs, showing similar levels of
engraftment in BM and similar capacity to colonize other
hematopoietic tissues. In addition, the engraftment composition
was comparable between h-CD34+ cells that had been co-cultured
with either BMSCs or CB-BFs (Fig. 5G).
DISCUSSION
Appropriate in vivomodels that canmimic the complex organization
of the bone marrow HSC niche have highlighted the fundamental
role of BMSCs in the generation and regulation of the hematopoietic
microenvironment. Although there is a general consensus that
BMSCs have the ability to establish a functional HSC niche, few
studies have actually explored whether cells derived from other
perinatal or adult tissue sources have a similar capacity (Reinisch
et al., 2015). Previously, it has been reported that circulating BBFs
with osteogenic character are very rare in mice and humans, but can
be routinely found in PB of guinea pigs. Interestingly, some clones
of guinea pig BBFs formed cartilage in vitro, and formed bone
and supported hematopoiesis upon in vivo transplantation with a
ceramic carrier (Kuznetsov et al., 2001). Here, we report that
CB-BFs can support the establishment of BM and hematopoietic
niches in vivo in pellet-derived ossicles. Similar to BM ossicles,
those generated from CB-BFs reproduce the architecture of natural
bone (cortical bone, medullary cavity), consisting of donor-derived
bone and host-derived sinusoids, and showing the establishment of
human CD146+ stromal cells within the BM compartment.
However, CB ossicles differed from BM ossicles in terms of
dimension and proportion of red and yellow marrow within the BM
compartment. Intra-ossicle murine hematopoiesis contained
committed lineages, as well as short-term and long-term HSCs in
both types of ossicles. In addition, h-CD34+ cells intravenously
Fig. 4. Features of human hematopoietic engraftment in
heterotopic ossicles. (A) Schematic representation of the
transplantation protocol. CB-BFs, or BMSCs as control, were induced to
form cartilage by culturing as pellets in the presence of TGFβ1 for
3 weeks. Pellets were then transplanted into immunocompromised
mice. At 3 weeks after transplantation, mice bearing heterotopic
ossicles were sublethally irradiated and transplanted intravenously with
human CB-derived CD34+ cells (hCD34+). The engraftment level within
mouse femur BM and in the heterotopic ossicles was evaluated 6 weeks
later. (B) Representative evaluation of human engraftment in PB,
spleen, mouse femur BM and ossicles (derived from BMSCs, n=9 and
from CB-BFs, n=22). (C) Representative cytofluorometric analysis of
human multilineage hematopoietic cells harvested from humanized BM
ossicles and CB ossicles, and from mouse femur BM.
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injected into immunodeficient mice previously implanted with
cartilage pellets could stably engraft into the ‘humanized niche’, as
demonstrated by the presence of human HSCs and HSC-derived
multilineage reconstitution. These in vivo data are correlated with
our in vitro results, which demonstrate the constitutive expression of
HSC maintenance genes in CB-BFs and their capacity to support
human HSCs in an ex vivo culture system.
Several in vitro studies have reported the expression of skeletal
markers by CB-BFs exposed to defined stimuli. Furthermore, the
successful differentiation of CB-BFs into cartilage in specific
chondrogenic medium has been previously demonstrated by our
group and by others (Zhang et al., 2011; Pievani et al., 2014; Kern
et al., 2006; Jäger et al., 2009; Ragni et al., 2013). In this study, we
further showed the expression of known skeletal development
regulators by CB-BFs in the absence of any inducing agents. The
pattern of expression was similar to that of BMSCs and revealed
baseline expression of key genes associated with cartilage and bone
formation, including RUNX2 and RUNX3, which are known to be
expressed in the growth plate during endochondral bone formation
(Wigner et al., 2013). Notably, in a recent study by Reinisch et al.,
these genes were found to be hypomethylated and overexpressed in
BMSCs, but not expressed or only slightly expressed in cell
populations isolated from tissue sources other than BM, such as
white adipose tissue, umbilical cord and skin (Reinisch et al., 2015).
In addition, we formally compared for the first time the chondroid
pellets generated by CB-BFs and BMSCs in standard micro-mass
cultures. We report that the two types of pellets displayed similar
cartilage-like morphology and levels of transcripts for
proteoglycans and chondrocyte-associated markers, such as
COL2A1, COL10A1, SOX9 and ACAN. However, the chondroid
rudiments generated by CB-BFs were consistently larger than those
generated by BMSCs, even though the rate of proliferation and the
frequency of precursors were comparable in both specimens, thus
suggesting a more efficient production of cartilaginous matrix in
vitro by the CB-derived progenitors compared with postnatal
BMSCs.
In contrast to a large number of in vitro investigations, only a
few studies have addressed the properties of CB-BFs in vivo.
Zhang and colleagues were able to demonstrate in vivo
osteogenesis by CB-BFs and to show the deposition of a large
Fig. 5. CB-BFs express CD146 and HSC niche genes and
support homeostasis of HSCs ex vivo. (A) Expression of
CD146 on BMSCs and CB-BFs at passages 3-4 of culture
analysed by flow cytometry using anti-human CD146 PE
(clone P1H12) (n=3). (B) Colony-forming efficiency (number of
colonies initiated by single CFU-Fs) of BMSCs and CB-BFs at
passages 3-4 (n=3). (C) Expression of HSC maintenance
genes (CXCL12, VCAM1, ANGPT1, KITLG, SPP1 and JAG1)
in BMSC and CB-BF populations by RT-PCR (n=6). (D) Total
number of non-adherent hematopoietic cells harvested after
7 days of co-culture of h-CD34+ cells with CB-BFs or BMSCs
(n=3). (E) Percentage of CD34+, CD34+/CD38+ and CD34+/
CD38− subpopulations detected by flow cytometry after 7 days
of co-culture of CB-CD34+ cells with CB-BFs or BMSCs (n=3).
(F) Clonogenic potential of h-CD34+ cells previously co-
cultured with CB-BFs or BMSCs (n=3). (G) Representative
analysis of multilineage and multi-organ human chimaerism in
NSG mice transplanted with h-CD34+ cells co-cultured on CB-
BFs and BMSCs monolayers. P values indicated have been
calculated with an unpaired two-tailed t-test.
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amount of newly formed bone in the pores of implanted scaffolds
(Zhang et al., 2011). In our recent work, subcutaneous
transplantation of CB-BFs in association with a ceramic carrier
resulted in the deposition not only of abundant histology-proven
bone but also of cartilage. The cartilaginous tissue was formed in
the absence of any ex vivo induction, thus demonstrating the
inherent capacity of CB-BFs to undergo chondrogenesis even in
the absence of specific inducing agents (Sacchetti et al., 2016).
However, in none of the previous studies was CB-BF
differentiation associated with the establishment of a
hematopoietic microenvironment (Zhang et al., 2011; Sacchetti
et al., 2016). The results presented here provide further
elucidation of the biology of CB-BFs, demonstrating that CB-
BFs were able to generate complete pellet-derived ossicles in vivo
in which a functional HSC niche was created. The progressive
substitution of cartilage by marrow in the ossicles likely occurred
through an ‘endochondral myelogenesis’ process previously
observed in cartilage pellets obtained from BMSCs (Serafini
et al., 2014). Interestingly, CB ossicles presented a different ratio
of red and yellow marrow compared with the BMSC-derived
counterpart, and showed a higher prevalence of red marrow, as
demonstrated by histomorphological analyses and by the number
of the hematopoietic cells harvested from the transplants. It can be
reasonably assumed that this feature of the CB ossicle correlates
with the perinatal origin of the donor cells and reproduces the
early developmental stages of BM ontogeny. In prenatal life and
in infants, in fact, almost the entire bone cavity is filled with red
BM, which is then partly replaced by fatty (yellow) marrow with
normal maturation (Małkiewicz and Dziedzic, 2012; Laor and
Jaramillo, 2009; Bain et al., 2010). Similar to ossicles derived
from BMSCs, the hematopoietic tissue within the CB ossicles
included mature cells of the erythroid, myeloid and
megakaryocytic lineages, as well as blood-cell progenitors, and
short-term and long-term HSCs. Moreover, CB-BFs did form a
completely humanized hematopoietic niche, in which human
HSCs engrafted and were maintained in a functional human
microenvironment. Although human ossicles are clearly
disadvantaged in their ability to host murine hematopoiesis
when compared with femur BM, we did not observe any
difference in the engraftment of human cells. One possible
explanation is that factors secreted by human stromal cells may
not be fully reactive with receptors on murine hematopoietic cells.
Moreover, the capacity of the heterotopic medullary cavity to
attract human HSCs suggests the establishment of a local cytokine
milieu resembling human marrow conditions. Our data indicate
that CB-BFs could exert a specific role in promoting migration of
HSCs into their BM niche. Further in vivo studies to trace the fate
of the injected cells will be instrumental to better understand the
homing of HSCs to the ossicles and the specific kinetics involved
in this process. Importantly, the expression of molecules involved
in mobility and cell adhesion, such as CXCL12 and VCAM-1 in
CB-BFs (albeit at lower levels, Markov et al., 2007; Wagner et al.,
2007) suggests their active role in HSC homing. Moreover, CB-BFs
express, like BMSCs, other genes involved in HSC maintenance,
such as ANGPT1, KITLG, SPP1 and JAG1, and support ex vivo
hematopoietic homeostasis in a co-culture system, providing
additional evidence of their capacity to preserve hematopoietic
progenitor properties. Taken together, the CB-BFs have many
features that are required for functionality in the HSC niche.
The results presented here appear to be in disagreement with our
previous study in which bone derived from CB-BFs did not support
hematopoiesis (Sacchetti et al., 2016). However, there is a substantial
difference in the present study, in that cartilage pellets were obtained
through ex vivo induction and, subsequently, bone, complete with a
medullary cavity, was formed in vivo through an endochondral
process. Therefore, we can assume that, in the case of CB-BFs, the
full expression of an endochondral bone formation program may be
required to obtain a marrow niche.
Recently, Reinisch et al. performed a comprehensive comparison
of different ‘MSC’ cell populations and demonstrated that the ability
to support the formation of a bone marrow microenvironment is
a unique property of BM-derived cells (Reinisch et al., 2015).
However, although Reinisch et al. used an experimental model
based on an endochondral process, the cells were cultured in a
different culture medium (10% human platelet lysate instead of
FBS) and were transplanted in vivo as undifferentiated cells
resuspended in a Matrigel-equivalent matrix. Most importantly,
the authors used ‘MSCs’ from the umbilical cord (UC), which are
very different from the fibroblasts derived from CB that we used in
this study (Reinisch et al., 2015). In particular, UC cells are not able
to form bone in vivo, even when transplanted with an
osteoconductive carrier (Kaltz et al., 2008; Todeschi et al., 2015).
Moreover, significant differences have been found in the global
gene expression profile of UC-derived cells and CB-BFs isolated
from the same donor and cultured under the same culture conditions
(Secco et al., 2009). Taken together, all these differences reinforce
the supposition that the UC cell population and CB-BFs population
are not the same.
The origin of CB-BFs in blood remaining in the umbilical vein
following birth is currently debated. It is possible that these cells are
established in the circulation early in prenatal life, as demonstrated
by studies on ‘MSC’ obtained from pre-term cord blood
(Campagnoli et al., 2001; Christensen et al., 2004; Surbek et al.,
1998; Wyrsch et al., 1999). Owing to the differences between UCs
and CB-BFs, it seems very unlikely that CB-BFs detach from the
cord and subsequently enter the circulation. Instead, it is possible
that these cells, together with HSCs, are travelling, via cord blood,
from early fetal hematopoietic sites to the newly formed BM
(Tavassoli, 1991; Erices et al., 2000). This suggests that the
ontological and anatomical origins of non-hematopoietic cells
derived from CB have a profound influence on their differentiation
capacities. Our results demonstrate that CB-BFs are a distinct and
privileged population of perinatal fibroblasts sharing with other
fetal stromal compartments (thymus, spleen and liver) and postnatal
BMSCs the extraordinary property of organizing the development
of a hematopoietic stem cell niche.
In conclusion, CB-BFs may represent a new and attractive
population of skeletal progenitor cells with some advantages over
BMSC. First, CB is usually regarded as medical waste and a large
amount of samples can be easily obtained at delivery with no risk to
the donor. Moreover, as perinatal tissue-derived cells, CB-BFs may
have some favourable features that result from their more-primitive
ontogenetic origin, including the absence of donor age-dependent
variation (Lee et al., 2004). Our data demonstrate that CB-BFs may
be used instead of BMSCs in specific experimental settings (e.g.
reproduction of bone and the HSC niche at heterotopic sites), and
warrant further exploration with the ultimate goal of possible
applications in regenerative medicine.
MATERIALS AND METHODS
Cell isolation and cartilage pellet generation
BMSCs were isolated from washouts of discarded BM collection bags of
paediatric and adult healthy donors, with informed consent according to
institutionally approved protocols, and processed as previously described
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(Gatto et al., 2012). CB-BFs were isolated from umbilical cord blood
samples collected from volunteer mothers during elective caesarean sections
at term (Pievani et al., 2014). Collections were performed after maternal
consent and in accordance with the ethical standards of the San Gerardo
(Monza) Hospital ethical committee.
BMSC and CB-BF strains were expanded for two or three passages and
then cultured for 3 weeks using a pellet culture system in 15 ml conical tubes
at a density of 3×105 cells/tube. Cultures were maintained in chondrogenic
differentiation medium consisting of DMEM-high glucose (Invitrogen)
supplemented with ITS+ premix (BD Biosciences), 1 mM sodium pyruvate
(Life Technologies), 50 μg/ml L-ascorbic acid 2-phosphate (Sigma-
Aldrich), 0.1 μM dexamethasone (Sigma-Aldrich), 0.1 mM non-essential
amino acid solution (Life Technologies) and 10 ng/ml transforming growth
factor β1 (TGFβ1) (R&D Systems). At the end of the in vitro culture,
chondrogenic differentiation was evaluated by histological and molecular
analysis.
Quantitative RT-PCR
Total RNAwas extracted from cells or cartilage pellets using Trizol reagent
(Life Technologies) and cDNA was generated as previously described
(Pievani et al., 2014). Quantitative RT-PCR analysis were performed using
the ABI 7900 Real-Time PCR system using gene-specific TaqMan Gene
Expression Assays and the TaqMan Universal PCR Master Mix (all from
Applied Biosystems). TaqMan Gene Expression Assays used are listed in
Table S1. Gene expression relative to GAPDH was quantified using the
2−ΔΔCt method.
In vivo transplantation
All animal procedures were approved by the relevant institutional
committees. Pellets were transplanted subcutaneously into 8- to 15-week-
old female SCID/beige mice (C.B-17/IcrHsd-PrkdcscidLystbg, Harlan) (≤16
samples/mouse) and harvested after 8 weeks, as previously described
(Serafini et al., 2014).
Histology and histomorphometry
Untransplanted cartilage pellets and heterotopic ossicles harvested at
8 weeks were fixed in 4% formaldehyde in phosphate buffer, decalcified in
10% EDTA, routinely processed for paraffin wax embedding, and used for
qualitative and quantitative histological analysis. Serial sections (5 μm)
were stained with Haematoxylin and Eosin, Alcian Blue, Toluidine Blue
and Picrosirius Red (all from Sigma-Aldrich). Staining with von Kossa
was performed on several untransplanted cartilage pellets embedded in
paraffin wax without decalcification. For quantitative analysis, a semi-
automatic image analyser (IAS 2000, Delta System, Rome, Italy) was used
to calculate the area of the untransplanted pellets and, in the heterotopic
transplants, the total area of the ossicles and the fraction of BM occupied by
adipose tissue.
Immunohistology
For the analysis of cell proliferation, untransplanted cartilage pellets
obtained from BMSCs and CB-BFs were immunostained for Ki-67 (clone
Mib1, 1:100, Dako, Denmark; DK-2600, Glostrup, Denmark). The colour
reaction was developed using 3,3′-diaminobenzidine tetrahydrochloride
(DAB, Sigma) as a substrate. Sections were counterstained with
Haematoxylin and the fraction of proliferative cells was determined as the
number of immunolabelled nuclei/the total of cells counted in the whole
section of each pellet.
To establish the contribution of human CB-BFs cells to the generation of
the different tissues within the heterotopic ossicles, immunofluorescence
experiments were performed using anti-huLaminA/C (EPR4100, 1:500,
Abcam) and anti-huCD146 (N1238, 1:25, Novocastra, Leica Biosystems).
Alexa Fluor 488-conjugated goat anti-rabbit (A-11008, Invitrogen) and
anti-mouse (A-21121, Invitrogen) were used as secondary antibodies for the
detection of the binding of anti-huLamA/C and anti-huCD146 antibodies,
respectively. Immunolabelled sections were analysed using a Leica TCS
SP5 confocal laser scanning microscopy system (Leica Microsystems).
Nuclei were stained with TOPRO-3 iodide (Invitrogen).
Bromodeoxyuridine/DNA analysis
BMSCs and CB-BFs at passage 3-4 were cultured for 48 h, incubated with
bromodeoxyuridine (BrdU) for 120 min and then harvested, washed and
fixed with 70% ice-cold ethanol and kept at 4°C before DNA staining. To
detect BrdU incorporated into DNA, fixed cells were incubated with anti-
BrdU monoclonal antibody (BD) and total cellular DNA content detected
by TO-PRO-3 iodide. Bi-parametric BrdU/DNA analysis was performed on
at least 10,000 cells using a FACS Calibur instrument (Becton Dickinson),
enabling a clear evaluation of the active S phase cell fraction (BrdU-positive
cells).
Evaluation of murine hematopoietic lineages and progenitor
cells
Total BM cells were obtained frommouse femurs or the ossicles by flushing
and subsequent collagenase digestion using 100 U/ml collagenase type II
(Gibco), filtered with 70 µm cell strainers (BD Biosciences) and treated with
ammonium chloride solution (Stem Cell Technologies), which lyses red
blood cells. To evaluate the presence of different hematopoietic lineages,
cells were stained with antibodies against CD45.2APC (clone 104, 17-0454,
dilution 1:100), Mac-1PE (M1/70, 12-0112, 1:100), Gr-1FITC (RB6-8C5,
11-5931, 1:250), CD41PE (MWReg30, 12-0411, 1:100) and Ter119PE
(TER-119, 12-5921, 1:100).
For evaluation of progenitors and HSCs, cells were incubated with a
mouse hematopoietic lineage eFluor450 cocktail (clones 17A2, RA3-6B2,
M1/70, TER-119, RB6-8C5, 88-7772, 1:5). Simultaneously, cells were
stained with c-kit APC (clone 2B8, 17-1171, 1:100), Sca-1PE (D7, 12-5981,
1:100), CD34 FITC (RAM34, 11-0341, 1:250) and Flk2 PerCP-eFluor710
(A2F10, 46-1351, 1:100) (for HSCs analysis) or FcγR (CD16/CD32)
PerCP-eFluor710 (93, 46-0161, 1:100) (for progenitors analysis). All
antibodies were from eBiosciences. Analyses were performed using a FACS
Canto II instrument with FACS DIVA software (BD).
Murine clonogenic hematopoietic progenitor assay
Hematopoietic clonogenic assays were performed in 35 mm low-adherent
surface dishes (Nunc) using 1 ml/dish of MethoCult GF M3434 semisolid
medium (Stem Cell Technologies) containing hematopoietic cytokines,
according to the manufacturer’s instructions. Single-cell suspensions
obtained from ossicles, mouse femurs and PB of ossicle-bearing mice
were plated in duplicate at 100,000 cells per dish. Colonies were scored after
14 days of incubation based on the morphological criteria as erythroid
(BFU-E), granulocyte/erythrocyte/macrophage/megakaryocyte (CFU-
GEMM), granulocyte/macrophage (CFU-GM), granulocyte (CFU-G) and
macrophage (CFU-M).
Hematopoietic reconstitution of ossicle-bearing mice
transplanted with human CD34+ cells
CD34+ progenitors from human CB were obtained by Ficoll-Paque Plus
(GE Healthcare Europe, Freiburg, Germany) separation of the mononuclear
fraction followed by immunomagnetic selection using the CD34
MicroBeads kit (Miltenyi Biotec) [with a median purity of 79% (range,
60 to 90%)].
Three weeks after pellet transplantation, mice were sublethally irradiated
(2.5 Gy) using a RADGIL X-Ray treatment unit (Gilardoni, Mandello del
Lario, Italy), followed the next day by intravenous injection of 3×105 CB-
derived human CD34+ cells. Six weeks after transplant of h-CD34+ cells,
the engraftment of human cells in PB, spleen, femurs and subcutaneous
ossicles was determined by flow cytometry after staining with anti-murine
CD45.2 APC and anti-human CD45 PE (clone HI30). Human
hematopoietic cells were stained with anti-CD45 (clone 2D1), CD19
(SJ25C1), -CD34 (8G12), -CD33 (P67.6), -CD64 (10.1) and -CD14
(M5E2, all BD Biosciences).
Colony-forming unit-fibroblast assays
The number of clonogenic progenitors at passage 3-4 was determined by the
colony-forming unit-fibroblast (CFU-F) assay. Briefly, BMSCs or CB-BFs
were seeded at clonal density (1.6 cells/cm2) and maintained for 14 days in
basal medium. To enumerate CFU-F, the cells were fixed with methanol,
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stained with Giemsa solution and scored at 10× magnification. The
experiment was performed in triplicate for each sample.
Co-culture of BMSCs/CB-BFs and cord blood CD34+ cells, and
ex vivo analyses of CD34+ cell homeostasis
CD34+ cells from human CB were obtained as described previously and
co-cultured on a confluent layer of BMSCs or CB-FBs in complete RPMI
medium (Euroclone) in 12-well plates. Number, phenotype, clonogenicity
and engraftment capacity of h-CD34+ cells were assessed after 7 days in
culture.
Briefly, non-adherent cells were collected, counted and stained with anti-
human CD34 PECy7 and CD38 PE (HIT2, BD Pharmingen). A total of
2×103 cells were seeded in MethoCult H4434 semisolid medium (Stem Cell
Technologies) following the manufacturer’s instructions. Hematopoietic
colonies after 14 days of culture were scored under an inverted microscope.
To evaluate the engraftment capacity, 3×105 h-CD34+ cells that have been
cultured on BMSCs or CB-BFs were transplanted into the tail vein of
sublethally irradiated NOD/LtSz-scidIL2Rγ−/− (NSG) mice. Mice were
euthanized 4 weeks after transplantation to evaluate human chimaerism.
Statistical analysis
Data are plotted as mean±s.d.; n is indicated in figure legends. Statistical
analyses were performed using an unpaired two-tailed Student’s t-test.
A P-value of less than 0.05 was considered to be statistically significant.
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